Hsbc Holdings PLC Aurinia Pharmaceuticals Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 15,616 shares of AUPH stock, worth $127,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,616

Previous 10,536 48.22%

Holding current value

$127,270

Previous $77,000 81.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$6.75 - $10.44 $34,290 - $53,035	5,080 Added 48.22%	15,616 $140,000
Q3 2024 Nov 14, 2024	SELL	$5.32 - $7.33 $21,370 - $29,444	-4,017 Reduced 27.6%	10,536 $77,000
Q2 2024 Aug 12, 2024	SELL	$4.81 - $5.78 $329,475 - $395,918	-68,498 Reduced 82.48%	14,553 $83,000
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $59,628 - $112,604	12,095 Added 17.05%	83,051 $416,000
Q4 2023 Feb 12, 2024	SELL	$7.13 - $9.49 $45,460 - $60,508	-6,376 Reduced 8.24%	70,956 $637,000
Q3 2023 Nov 13, 2023	SELL	$7.77 - $12.27 $20,730 - $32,736	-2,668 Reduced 3.34%	77,332 $600,000
Q1 2023 May 15, 2023	SELL	$5.94 - $11.27 $13,679 - $25,954	-2,303 Reduced 2.8%	80,000 $876,000
Q4 2022 Feb 14, 2023	SELL	$4.11 - $8.14 $3,456 - $6,845	-841 Reduced 1.01%	82,303 $355,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $999,419 - $1.86 Million	-150,063 Reduced 64.35%	83,144 $632,000
Q2 2022 Aug 11, 2022	SELL	$8.95 - $12.8 $2.24 Million - $3.2 Million	-250,056 Reduced 51.74%	233,207 $2.32 Million
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $26,109 - $58,403	2,598 Added 0.54%	483,263 $6.08 Million
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $7.27 Million - $13.5 Million	409,080 Added 571.46%	480,665 $11 Million
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $628,977 - $1.36 Million	57,546 Added 409.9%	71,585 $1.6 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $140,390 - $203,846	14,039 New	14,039 $181,000
Q1 2021 May 14, 2021	SELL	$12.3 - $18.73 $144,709 - $220,358	-11,765 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$12.94 - $16.05 $2,148 - $2,664	-166 Reduced 1.39%	11,765 $162,000
Q3 2020 Nov 12, 2020	SELL	$13.19 - $16.66 $43,777 - $55,294	-3,319 Reduced 21.76%	11,931 $175,000
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $215,330 - $279,532	15,250 New	15,250 $248,000

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.16B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Aurinia Pharmaceuticals Inc. Transaction History